Concepedia

Kinase inhibitor roscovitine as a PB2 cap-binding inhibitor against influenza a virus replication

Qi Huang, Yingyuan Zhong, Jingyan Li, Yilu Ye, Wenjiao Wu, Lizhu Chen, Mingkai Feng, Jie Yang, Shuwen Liu

Biochemical and Biophysical Research Communications · 2020 · 15 citations · 14 references

DOI

Concepts

References

14

The structural basis for cap binding by influenza virus polymerase subunit PB2

Delphine Guilligay, Franck Tarendeau, Patricia Resa‐Infante et al. · Nature Structural & Molecular Biology · 2008 · 484 citations

, , +13

Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry

Wenjiao Wu, Richan Li, Xianglian Li et al. · Viruses · 2015 · 429 citations · Full text

, , +17

Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2

Michael P. Clark, Mark W. Ledeboer, Ioana Davies et al. · Journal of Medicinal Chemistry · 2014 · 211 citations · Full text

, , +17

Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit

Randal A. Byrn, Hamilton B. Bennett, Chris Bral et al. · Antimicrobial Agents and Chemotherapy · 2014 · 188 citations · Full text

, , +17

Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus

Terrence M. Tumpey, Adolfo García‐Sastre, Jeffery K. Taubenberger et al. · Proceedings of the National Academy of Sciences · 2004 · 176 citations · Full text

, , +16